The therapeutic potential of anti-cytokine strategies in central nervous system ischaemia

Expert Opinion on Investigational Drugs

Volumn 6, Issue 4, 1997, Pages 407-415

  Clark, W M ^a   Lutsep, H L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

central nervous system; cytokines; interleukin 1 receptor antagonist; interleukins; stroke

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL MODEL; BLOOD LEVEL; BRAIN ISCHEMIA; BRAIN LEVEL; CELL INFILTRATION; CLINICAL TRIAL; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MEDIATOR; NEUROPROTECTION; NONHUMAN; REPERFUSION INJURY; REVIEW; STROKE;

EID: 0030901359     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.4.407     Document Type: Review

References (72)